Skip to Content
Skip to Content

Substance evaluation - CoRAP

Substance evaluation - CoRAP

For each substance, the table shows the evaluating Member State, the year of evaluation and a short description of the concern which led to it being placed on the list.

Community rolling action plan (CoRAP): The community rolling action plan covers three consecutive years and is updated mid of March every year. From this it follows that substances in the table below with the column ‘Year’ indicating a current or future year, are those that have been prioritised for evaluation, and are effectively on the current CoRAP.

Documents to do with substance evaluation are also available here. They include: documents justifying selection of the substances, decisions to request more information. Member States' conclusions and Member States' final evaluation reports are included for substances for which evaluation has been finalised.

 

Notes to the Substance Evaluation and CoRAP table
  • Where two Members States are indicated, this is a joint evaluation. The first Member State mentioned leads the Evaluation and is the responsible competent authority in the meaning of Article 45(2) of REACH.
  • The substance public name is used. In most of the cases it is the name as disseminated on the ECHA website.
  • When the EC Number is not available, the number assigned to substance by ECHA after the inquiry process is used.
  • When the substances are included in the CoRAP, they have not yet been evaluated and thus the concern is indicative and not exhaustive or conclusive.
  • Contact details of the evaluating Member States are provided for all the substance included.
  • Please note that the justification document explains the grounds of the initial concerns that triggered the inclusion of the substance in the CoRAP for further clarification under substance evaluation. The justification document is based on a preliminary screening of the substance and is without prejudice to the outcome of the substance evaluation.

Legend:

  • Suspected PBT/vPvB: Potentially Persistent, Bioaccumulative and Toxic/very Persistent and very Bioaccumulative.
  • CMR: generic term for known carcinogenic and/or mutagenic and/or reprotoxic properties (according to CLP harmonised or registrant self-classification or CLP Inventory). The concern can refer to C, M, R or a combination of those.
  • Suspected CMR: generic term for suspected carcinogenic and/or mutagenic and/or reprotoxic properties (not classified according to CLP harmonised or registrant self-classification). The concern can refer to (suspected) C, M, R or a combination of those.
  • Sensitiser: generic term for known sensitising properties (according to CLP harmonised or registrant self-classification or CLP Inventory).
  • Suspected sensitiser: generic term for suspected sensitising properties (not classified according to CLP harmonised or registrant self-classification).
  • RCR: Risk Characterisation Ratio
Last updated 26 November 2019. Database contains 375 unique substances/entries.
Filter the list
Initial grounds for concern:

 
270-877-4
68479-98-1
2016
Denmark
Suspected Mutagenic
Suspected Reprotoxic
Ongoing
Details
233-072-9
10028-22-5
Lithuania
Suspected Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Not started
Details
249-044-4
28472-97-1
2013
Italy
Consumer use
High (aggregated) tonnage
Suspected PBT/vPvB
Wide dispersive use
Information requested
Details
246-835-6
25321-09-9
2020
France
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of workers
Not started
Details
247-660-8
26401-35-4
2013
Spain
Suspected PBT/vPvB
High (aggregated) tonnage
Other exposure/risk based concern
Wide dispersive use
Concluded
Details
214-189-4
1112-39-6
2020
Belgium
Reprotoxic
Other hazard based concern
Exposure of workers
Not started
Details
210-871-0
624-92-0
2014
Germany
Exposure of environment
High (aggregated) tonnage
Other exposure/risk based concern
Concluded
Details
214-277-2
1119-40-0
2014
Poland
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
212-783-8
868-85-9
2012
Netherlands
CMR
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
234-126-4
10544-72-6
Latvia
Suspected Mutagenic
Suspected Reprotoxic
Exposure of workers
High RCR
Not started
Details
212-791-1
870-08-6
2021
Austria
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Not started
Details
278-355-8
75980-60-8
2020
Sweden
Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Sensitiser
Exposure of workers
Wide dispersive use
Not started
Details
215-575-5
1332-77-0
2017
Lithuania
Reprotoxic
Consumer use
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
205-117-2
133-66-4
Italy
Suspected PBT/vPvB
Wide dispersive use
Not started
Details
231-673-0
7681-57-4
2014
Hungary
Suspected CMR
Exposure of environment
Exposure of sensitive populations
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
229-912-9
6834-92-0
2015
Latvia
Suspected Reprotoxic
Consumer use
High (aggregated) tonnage
High RCR
Concluded
Details
248-948-6
28299-41-4
2014
Netherlands
Suspected PBT/vPvB
High (aggregated) tonnage
Follow-up
Details
287-401-6
85507-79-5
2014
Denmark
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Ongoing
Details
206-354-4
330-54-1
2014
Finland
Potential endocrine disruptor
Other exposure/risk based concern
Wide dispersive use
Ongoing
Details
205-492-2
141-63-9
2015
Norway
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Information requested
Details
405-420-1
-
2020
Sweden
Suspected Reprotoxic
Potential endocrine disruptor
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Not started
Details
941-303-6
-
2021
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Not started
Details
609-946-4
41637-38-1
2021
Germany
Suspected PBT/vPvB
Exposure of environment
Not started
Details
404-740-9
115895-09-5
2016
Slovenia
Suspected PBT/vPvB
Exposure of environment
Information requested
Details
204-399-4
120-47-8
2021
Germany
Potential endocrine disruptor
Not started
Details
202-597-5
97-63-2
2014
Italy
Suspected CMR
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
202-510-0
96-49-1
2018
Latvia
Suspected Reprotoxic
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
211-063-0
628-96-6
2016
Italy
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Suspected Sensitiser
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
200-849-9
75-21-8
2012
Austria
CMR
High (aggregated) tonnage
Concluded
Details
629-732-4
1224966-13-5
2015
Lithuania
Sensitiser
Exposure of sensitive populations
Exposure of workers
Concluded
Details
272-902-4
68919-76-6
2021
Germany
Suspected PBT/vPvB
Exposure of environment
Not started
Details
200-001-8
50-00-0
2013
France
CMR
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
500-006-8
9003-36-5
2020
Denmark
Potential endocrine disruptor
Not started
Details
202-626-1
98-00-0
2013
Poland
CMR
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
931-274-8
-
2014
Slovenia
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
204-127-4
116-15-4
2015
Italy
Suspected CMR
High (aggregated) tonnage
Ongoing
Details
203-492-7
107-46-0
2013
Norway
Suspected CMR
Consumer use
High (aggregated) tonnage
Information requested
Details
228-408-6
6259-76-3
2012
Netherlands
Suspected CMR
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
701-057-0
-
2020
Germany
Suspected PBT/vPvB
Exposure of environment
High RCR
Wide dispersive use
Not started
Details
204-617-8
123-31-9
2012
Italy
CMR
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
206-019-2
288-32-4
2012
United Kingdom
CMR
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
931-745-8
-
2014
Sweden
Suspected PBT/vPvB
Exposure of environment
High RCR
Follow-up
Details
938-828-8
-
2020
Sweden
Suspected Reprotoxic
Potential endocrine disruptor
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Not started
Details
404-800-4
118832-72-7
2014
Germany
Suspected PBT/vPvB
Concluded
Details
250-610-8
31394-54-4
2012
Latvia
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
275-702-5
71617-10-2
2016
Germany
Potential endocrine disruptor
Consumer use
Wide dispersive use
Information requested
Details
249-535-3
29253-36-9
2020
Austria
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Not started
Details
203-584-7
108-45-2
2018
Latvia
Suspected Reprotoxic
Sensitiser
Exposure of workers
High (aggregated) tonnage
Concluded
Details
247-722-4
26471-62-5
2012
Poland
CMR
Suspected PBT/vPvB
Sensitiser
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-576-3
108-38-3
2015
Germany
Suspected CMR
Suspected Sensitiser
Consumer use
Cumulative exposure
High (aggregated) tonnage
High RCR
Wide dispersive use
Information requested
Details
203-571-6
108-31-6
2013
Austria
Sensitiser
High (aggregated) tonnage
High RCR
Concluded
Details
201-202-3
79-39-0
2016
Sweden
Other hazard based concern
Exposure of workers
Information requested
Details
248-666-3
27813-02-1
2014
France
Suspected CMR
Sensitiser
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Ongoing
Details
200-659-6
67-56-1
2012
Poland
Suspected CMR
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Concluded
Details
202-785-7
99-76-3
2014
France
CMR
Potential endocrine disruptor
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
201-297-1
80-62-6
2014
France
Sensitiser
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
204-317-7
119-36-8
2015
France
Suspected CMR
Consumer use
High (aggregated) tonnage
Follow-up
Details
203-475-4
107-25-5
2018
Latvia
Suspected Reprotoxic
Consumer use
Exposure of sensitive populations
Exposure of workers
Other exposure/risk based concern
Concluded
Details
203-624-3
108-87-2
2013
Finland
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
429-320-2
24748-23-0
2019
Netherlands
PBT/vPvB
Ongoing
Details
448-020-2
-
2013
Slovakia
CMR
Suspected PBT/vPvB
High RCR
Concluded
Details
700-427-9
-
2013
Belgium
Suspected PBT/vPvB
Consumer use
Wide dispersive use
Concluded
Details
show/hide
Tangled Multi-Walled Carbon Nanotubes EC / List no: 701-160-0 | CAS no: -
-
-
2019
Germany
Suspected Carcinogenic
Other hazard based concern
Consumer use
Cumulative exposure
Exposure of environment
Wide dispersive use
Ongoing
Details
221-375-9
3081-14-9
2012
Belgium
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details
205-201-9
135-57-9
2014
Belgium
Suspected PBT/vPvB
Exposure of environment
Conclusion under preparation
Details
251-118-6
32588-76-4
2017
Norway
Suspected PBT/vPvB
Other hazard based concern
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Ongoing
Details
225-625-8
4979-32-2
2013
Germany
Suspected CMR
Suspected PBT/vPvB
Sensitiser
Consumer use
Exposure of workers
Wide dispersive use
Concluded
Details
223-055-4
3710-84-7
2019
Sweden
Suspected Carcinogenic
Suspected Mutagenic
Ongoing
Details
221-374-3
3081-01-4
2012
Austria
Suspected PBT/vPvB
Wide dispersive use
Ongoing
Details
201-983-0
90-30-2
2012
Germany
Suspected PBT/vPvB
Wide dispersive use
Ongoing
Details
629-767-5
1228186-18-2
2021
Germany
Exposure of environment
Suspected PBT/vPvB
Wide dispersive use
Not started
Details
267-636-0
67905-17-3
2019
Belgium
Suspected PBT/vPvB
Ongoing
Details
214-263-6
1118-46-3
2018
France
Suspected Mutagenic
Suspected Reprotoxic
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Suspended
Details
203-777-6
110-54-3
2012
Germany
CMR
Other hazard based concern
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
202-870-9
100-61-8
2021
Poland
Suspected Carcinogenic
Suspected Mutagenic
Cumulative exposure
Exposure of workers
High RCR
Wide dispersive use
Not started
Details
202-049-5
91-20-3
2016
United Kingdom
Exposure of workers
High (aggregated) tonnage
High RCR
Other exposure/risk based concern
Concluded
Details
1 - 2.5 moles ethoxylated
500-209-1
68412-54-4
2016
United Kingdom
Potential endocrine disruptor
Other hazard based concern
High (aggregated) tonnage
Concluded
Details
209-909-9
597-82-0
2016
Netherlands
Suspected PBT/vPvB
Information requested
Details
202-422-2
95-47-6
2015
Germany
Suspected CMR
Suspected Sensitiser
Consumer use
Cumulative exposure
High (aggregated) tonnage
High RCR
Wide dispersive use
Information requested
Details
217-421-2
1843-05-6
2013
Italy
Potential endocrine disruptor
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
220-260-0
2691-41-0
2020
Hungary
Suspected Carcinogenic
Suspected Reprotoxic
Exposure of environment
Exposure of workers
Wide dispersive use
Not started
Details
203-497-4
107-51-7
2015
Norway
Suspected PBT/vPvB
Consumer use
Wide dispersive use
Follow-up
Details
The complex combination of hydrocarbons produced by the distillation of products from the hydrogenation of isononanal. It consists predominantly of C6 olefins and paraffins and C9 alcohols and aldehydes and boiling in the range of approximately 110°C to 202°C (230°F to 396°F).
273-110-1
68938-03-4
2021
Slovenia
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Not started
Details
228-250-8
6197-30-4
2012
France
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
700-960-7
-
2012
Denmark
Potential endocrine disruptor
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
271-846-8
68609-97-2
2021
Ireland
Suspected Mutagenic
Sensitiser
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
Not started
Details
205-031-5
131-57-7
2014
Denmark
Potential endocrine disruptor
Cumulative exposure
Exposure of environment
Exposure of sensitive populations
Exposure of workers
Wide dispersive use
Ongoing
Details
204-407-6
120-55-8
2019
Latvia
Suspected Reprotoxic
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
211-745-8
693-21-0
2016
Italy
Suspected Carcinogenic
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
High RCR
Conclusion under preparation
Details
248-258-5
27138-31-4
2019
Latvia
Suspected Reprotoxic
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Ongoing
Details
201-280-9
80-46-6
2014
Germany
Potential endocrine disruptor
Consumer use
Wide dispersive use
Ongoing
Details
225-716-2
5026-74-4
2021
Denmark
Suspected Mutagenic
Suspected Sensitiser
Consumer use
Exposure of workers
Not started
Details
203-398-6
106-44-5
2015
United Kingdom
Suspected CMR
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-396-5
106-42-3
2015
Germany
Suspected CMR
Suspected Sensitiser
Consumer use
Cumulative exposure
High (aggregated) tonnage
High RCR
Wide dispersive use
Information requested
Details
200-752-1
71-41-0
2016
Lithuania
Suspected Sensitiser
Consumer use
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
206-420-2
338-83-0
2020
Belgium
Suspected PBT/vPvB
Exposure of environment
Not started
Details
204-500-1
121-82-4
2020
Hungary
Suspected Carcinogenic
Suspected Reprotoxic
Exposure of environment
Exposure of workers
Wide dispersive use
Not started
Details
201-344-6
81-33-4
2021
Belgium
Suspected PBT/vPvB
Not started
Details
203-632-7
108-95-2
2015
Denmark
Suspected Mutagenic
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
High RCR
Ongoing
Details
271-867-2
68610-51-5
2016
Spain
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Information requested
Details
284-325-5
84852-15-3
2014
Spain
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
310-154-3
121158-58-5
2018
Germany
Potential endocrine disruptor
Concluded
Details
272-486-4
68855-45-8
2016
France
CMR
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
701-251-5
-
2013
Netherlands
CMR
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
262-975-0
61788-44-1
2014
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Cumulative exposure
Ongoing
Details
701-266-7
-
2018
Czech Republic
Sensitiser
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Conclusion under preparation
Details
-
-
2017
Germany
Suspected PBT/vPvB
Exposure of environment
Ongoing
Details
468-710-7
754-12-1
2012
Germany
Other hazard based concern
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
444-340-1
-
2017
Germany
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
231-760-3
7722-64-7
2017
France
Suspected Reprotoxic
Consumer use
Exposure of sensitive populations
Concluded
Details
432-240-0
12056-51-8
2017
France
Carcinogenic
Exposure of workers
Information requested
Details
219-006-1
2312-35-8
2019
Netherlands
Potential endocrine disruptor
Suspected PBT/vPvB
Ongoing
Details
202-307-7
94-13-3
2015
Belgium
Suspected Reprotoxic
Potential endocrine disruptor
Consumer use
Exposure of environment
Exposure of sensitive populations
Wide dispersive use
Information requested
Details
203-686-1
109-60-4
2021
Ireland
Suspected Reprotoxic
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Not started
Details
295-835-2
92129-33-4
2015
Italy
Exposure of environment
High (aggregated) tonnage
Other exposure/risk based concern
Wide dispersive use
Concluded
Details
264-120-7
63393-96-4
2017
Italy
Suspected PBT/vPvB
Exposure of environment
High RCR
Wide dispersive use
Information requested
Details
EC No. 415-490-5 and 604-250-7
-
-
2016
Germany
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Concluded
Details
422-270-2
-
2019
Spain
Suspected PBT/vPvB
Ongoing
Details
915-730-3
-
2017
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Exposure of environment
High RCR
Wide dispersive use
Ongoing
Details
473-390-7
-
2016
Belgium
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Information requested
Details
907-745-9
-
2015
Belgium
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
906-484-8
-
2015
Slovenia
Suspected PBT/vPvB
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
905-806-4
-
2015
Estonia
CMR
Suspected PBT/vPvB
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
905-562-9
-
2020
Germany
Suspected Reprotoxic
Suspected Sensitiser
Other hazard based concern
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
High RCR
Wide dispersive use
Not started
Details
905-588-0
-
2020
Germany
Suspected Reprotoxic
Suspected Sensitiser
Other hazard based concern
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
High RCR
Wide dispersive use
Not started
Details
700-161-3
-
2013
Netherlands
Suspected PBT/vPvB
Ongoing
Details
430-050-2
-
2017
Spain
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Concluded
Details
403-030-6
137398-54-0
Belgium
Suspected PBT/vPvB
Follow-up
Details
911-815-4
-
2020
Denmark
Suspected Carcinogenic
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Cumulative exposure
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Not started
Details
412-780-3
-
France
Suspected PBT/vPvB
Conclusion under preparation
Details
931-384-6
-
2013
Slovenia
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Concluded
Details
701-241-0
-
2020
Italy
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Not started
Details
266-042-9
65997-13-9
2015
Finland
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
264-848-5
64365-17-9
2015
Finland
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
203-585-2
108-46-3
2016
Finland
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-585-2
108-46-3
2019
France
Potential endocrine disruptor
High (aggregated) tonnage
Ongoing
Details
401-850-9
255881-94-8
2014
Belgium
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Follow-up
Details
700-579-6
-
2017
Netherlands
Suspected PBT/vPvB
Wide dispersive use
Ongoing
Details
447-780-2
-
2014
Estonia
Suspected CMR
Suspected PBT/vPvB
Exposure of environment
Exposure of workers
Ongoing
Details
This entry covers synthetic amorphous silicon dioxide as a nanomaterial in the form of stable aggregated particles of particle size > 1 μm, with primary particles of nanosize
231-545-4
7631-86-9
2012
Netherlands
Other hazard based concern
Other exposure/risk based concern
Information requested
Details
231-131-3
7440-22-4
2014
Netherlands
Other hazard based concern
High (aggregated) tonnage
Other exposure/risk based concern
Wide dispersive use
Concluded
Details
204-857-3
127-68-4
2020
Ireland
Suspected Reprotoxic
Other hazard based concern
Exposure of workers
High (aggregated) tonnage
Not started
Details
231-836-6
7758-19-2
2019
Hungary
Suspected Mutagenic
Suspected Reprotoxic
Exposure of workers
Wide dispersive use
Ongoing
Details
231-890-0
7775-14-6
2016
Austria
Suspected Carcinogenic
Suspected Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
205-739-4
149-44-0
2021
Netherlands
Suspected Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Not started
Details
231-511-9
7601-89-0
2015
Germany
Suspected Carcinogenic
Potential endocrine disruptor
Other hazard based concern
Exposure of workers
Wide dispersive use
Concluded
Details
203-570-0
108-30-5
2013
Austria
Suspected CMR
Sensitiser
High (aggregated) tonnage
High RCR
Concluded
Details
216-653-1
1634-04-4
2014
France
Potential endocrine disruptor
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
210-382-2
614-45-9
2013
Italy
Sensitiser
Consumer use
Wide dispersive use
Follow-up
Details
246-563-8
25013-16-5
2015
France
Suspected Reprotoxic
Potential endocrine disruptor
Consumer use
Exposure of sensitive populations
Wide dispersive use
Suspended
Details
204-825-9
127-18-4
2013
Latvia
CMR
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-726-8
109-99-9
2013
Germany
CMR
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
260-830-6
57583-54-7
2020
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Not started
Details
205-286-2
137-26-8
2014
Sweden
Potential endocrine disruptor
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
231-302-2
7488-55-3
2016
France
Suspected CMR
Sensitiser
Consumer use
High (aggregated) tonnage
Information requested
Details
236-675-5
13463-67-7
2018
France
Carcinogenic
Suspected Mutagenic
Other hazard based concern
Ongoing
Details
203-625-9
108-88-3
2012
Finland
CMR
Other hazard based concern
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
484-450-7
-
2019
Spain
Suspected PBT/vPvB
Ongoing
Details
204-800-2
126-73-8
2012
Hungary
CMR
Other hazard based concern
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
202-924-1
101-20-2
2019
France
Suspected Reprotoxic
Potential endocrine disruptor
Wide dispersive use
Ongoing
Details
222-182-2
3380-34-5
2012
Netherlands
Potential endocrine disruptor
Suspected PBT/vPvB
High (aggregated) tonnage
Information requested
Details
214-685-0
1185-55-3
2013
Sweden
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
220-449-8
2768-02-7
2013
Sweden
Suspected Sensitiser
Exposure of sensitive populations
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Follow-up
Details
203-929-1
112-03-8
Italy
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Not started
Details
204-112-2
115-86-6
2017
France
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
202-908-4
101-02-0
2013
United Kingdom
Suspected CMR
Potential endocrine disruptor
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
222-020-0
3319-31-1
2012
Austria
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
701-028-2
-
2013
France
Suspected PBT/vPvB
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
High RCR
Wide dispersive use
Ongoing
Details
809-930-9
1330-78-5
2014
Netherlands
Suspected PBT/vPvB
Other hazard based concern
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
237-159-2
13674-87-8
2020
Germany
Potential endocrine disruptor
Not started
Details
246-677-8
25155-23-1
2014
Italy
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Suspected PBT/vPvB
Wide dispersive use
Follow-up
Details
231-944-3
7779-90-0
2013
Romania
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-545-4
108-05-4
2019
Latvia
Suspected Reprotoxic
Potential endocrine disruptor
Suspected Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
215-535-7
1330-20-7
2020
Germany
Suspected CMR
Suspected Sensitiser
Consumer use
Cumulative exposure
High (aggregated) tonnage
High RCR
Wide dispersive use
Not started
Details
215-222-5
1314-13-2
2017
Germany
Other hazard based concern
Consumer use
Exposure of environment
Other exposure/risk based concern
Wide dispersive use
Information requested
Details
205-288-3
137-30-4
2012
Denmark
Potential endocrine disruptor
High RCR
Information requested
Details

Export search results to:

Categories Display

Tagged as:

(click the tag to search for relevant content)


Route: .live1